These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 286738)

  • 1. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
    Lotzová E; Savary CA; Gutterman JU; Hersh EM
    Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
    Trinchieri G; Santoli D; Granato D; Perussia B
    Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of the cytotoxic effect of tumor cells against the targets of normal killers].
    Fuks BB; Zedginidze MS; Spirande IV; Kogarko IN; Sterlina AG
    Biull Eksp Biol Med; 1981 Sep; 92(9):342-5. PubMed ID: 7295991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
    Lee SH; Kelley S; Chiu H; Stebbing N
    Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of natural and activated human antitumour cytotoxicity by human seminal plasma.
    Rees RC; Vallely P; Clegg A; Potter CW
    Clin Exp Immunol; 1986 Mar; 63(3):687-95. PubMed ID: 2423280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-induced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism.
    Trinchieri G; Granato D; Perussia B
    J Immunol; 1981 Jan; 126(1):335-40. PubMed ID: 7451975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody-dependent cellular cytotoxicity (AAZZ) against leukemia cells--K-cell activity of human leukocytes].
    Thränhardt H; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):824-40. PubMed ID: 6162750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of human spontaneous cell-mediated cytotoxicity.
    Pollack SB; Emmons SL
    J Immunol; 1979 Jul; 123(1):160-5. PubMed ID: 448145
    [No Abstract]   [Full Text] [Related]  

  • 13. Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.
    Kabelitz D; Kunkel HG
    J Immunol; 1983 Jun; 130(6):2505-7. PubMed ID: 6189890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of natural killer activity and antibody-dependent cellular cytotoxicity by cultured human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1981 Jun; 126(6):2221-9. PubMed ID: 6453160
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural cytotoxicity, responsiveness to interferon and morphology of intra-epithelial lymphocytes from the small intestine of the rat.
    Flexman JP; Shellam GR; Mayrhofer G
    Immunology; 1983 Apr; 48(4):733-41. PubMed ID: 6187670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.